Yahoo Web Search

Search results

1. • 

     Sanofi Earns Price Target Cut After Stopping Breast Cancer Drug Trial

     Benzinga via Yahoo Finance· 2 years ago

     Sanofi SA (NASDAQ: SNY) discontinued the development of its oral SERD amcenestrant following a...

2. • 

     Sanofi (SNY) Ends Development of Breast Cancer Drug, Stock Down

     Zacks via Yahoo Finance· 2 years ago

     Shares of Sanofi SNY were down 5.8% in the pre-market trading session on Aug 17, after management...

3. • 

     Sanofi Ends Development Of Breast Cancer Drug Amcenestrant After Trial Failure

     Benzinga via Yahoo Finance· 2 years ago

     Sanofi SA (NASDAQ: SNY) said it would stop further work on breast cancer drug amcenestrant, putting...

4. • 

     Novartis Announces Positive Data on Breast Cancer Drug Kisqali

     Zacks via Yahoo Finance· 12 months ago

     Novartis NVS announced positive data on the breast cancer drug Kisqali (ribociclib) from the...

5. • 

     Bristol Myers, Pfizer, AbbVie drugs likely to face U.S. price negotiation

     Reuters via Yahoo Finance· 1 year ago

     The blood thinner Eliquis from Bristol Myers Squibb, Pfizer's breast cancer drug Ibrance and...

6. • 

     Sanofi trial failure halts work on breast cancer treatment amcenestrant

     Reuters via Yahoo News· 2 years ago

     Sanofi has stopped further work on amcenestrant, a treatment once seen to have strong commercial...

7. • 

     Pfizer (PFE), Arvinas Post Upbeat Data From Breast Cancer Study

     Zacks via Yahoo Finance· 6 months ago

     Interim data from an early-stage study shows that treatment with Pfizer (PFE)/Arvinas' (ARVN) breast...

8. • 

     Pfizer CEO calls US drug price plan 'negotiation with a gun to your head'

     Reuters via Yahoo News· 1 year ago

     NEW YORK (Reuters) -Pfizer Inc Chief Executive Albert Bourla called U.S. plans to negotiate drug...

9. • 

     Novartis pauses enrollment in some Kisqali trials to fix manufacturing

     BioPharma Dive via Yahoo Finance· 2 months ago

     The company said the pause is necessary to meet regulatory limits on nitrosamine, but added it will...

10. • 

      Which drugs will be selected for Medicare negotiations? Here’s what we know

      The Hill via Yahoo News· 10 months ago

      The first 10 drugs selected for Medicare price negotiation will be announced by Sep. 1 and will set...